#276 ‒ Special episode: Peter answers questions on longevity, supplements, protein, fasting, apoB, statins, and more
whatshot 1090 snips
Oct 23, 2023
Delve into the fascinating prospects of living to 120 and the optimistic theories around longevity. Discover Peter's personalized supplement regimen and the complexities of cholesterol management. The discussion emphasizes the importance of individualized nutrition, especially regarding protein intake and maintaining muscle mass. Explore health-tracking wearables and their impact on metabolic health. Together, these insights challenge conventional wisdom and inspire listeners to rethink their approach to health and longevity.
01:19:15
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
question_answer ANECDOTE
Risky Teen Games
As a teenager, Attia played a risky game of flattening coins on train tracks.
A friend's brother tragically died playing chicken with a subway train, illustrating high risk, no reward scenarios.
volunteer_activism ADVICE
Evaluate Risk-Reward
When considering interventions, evaluate the risk-reward ratio.
Be cautious of unproven supplements with high risks and unclear benefits.
volunteer_activism ADVICE
Peter Attia's Supplement Regimen
Peter Attia takes EPA/DHA, vitamin D, magnesium, methylfolate, methyl B12, and a baby aspirin, among others.
Don't blindly copy his regimen; understand the rationale, individual needs, and potential risks.
Get the Snipd Podcast app to discover more snips from this episode
In this special episode of The Drive, Peter discusses a variety of topics, breaking away from the typical deep-dive format to explore a wide range of common questions submitted by listeners. Peter tackles subjects like the viability of living to 120 and beyond, addressing some of the optimistic theories regarding achievement of this remarkable feat. Peter then shares his drug and supplement regimen while emphasizing how individualized these protocols need to be. The conversation also touches on lowering apoB, the long-term use of statins, the myth of good vs. bad cholesterol, the complexities of nutrition research, the quest for the ideal diet, and Peter's strategies for hitting daily protein goals. Peter finishes with a discussion about his favorite health-tracking wearables, the role of CGM in non-diabetics, and more.
We discuss:
Overview of topics and previous episodes of a similar format [2:45];
The viability of living to 120 and beyond: some optimistic theories [4:45];
The potential of mTOR inhibition as a mid-life intervention, and longevity potential for the next generation [13:30];
A framework for thinking about geroprotective drugs and supplements in the context of a lack of aging biomarkers [17:00];
Supplements Peter takes and how his regimen has changed in the last year [26:15];
Pharmacologic strategies to lower ASCVD risk, the limitations of statins, nutritional interventions, and more [36:15];
Misnomers about cholesterol [48:00];
Why nutritional research is so challenging, some general principles of nutrition, and why Peter stopped doing prolonged fasts [50:45];
Optimizing protein intake [59:45];
Wearables for sleep and exercise, continuous glucose monitors (CGM), and a continuous blood pressure monitor on the horizon [1:04:45]; and
The Peter Attia Drive